The latest data point in Q4'26 shows total operating expenses of $142.2M, with R&D Expenses at $90.5M and SG&A Expenses at $51.7M. From Q1'24 to Q4'26, both R&D and SG&A expenses demonstrated consistent growth, with R&D Expenses increasing from $22.6M to $90.5M and SG&A Expenses rising from $12.5M to $51.7M, reflecting accelerating investment in research activities and operational scaling over the nine-quarter period.